FibroBiologics Announces Three United States Patents for Fibroblast Technology
/PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and...
Stay updated with breaking news from Direct Offering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and...
HOUSTON, Feb. 6, 2024 /PRNewswire/ -- FibroBiologics , a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts...
/PRNewswire/ -- FibroBiologics, Inc. ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures...
/PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid...
Management's Discussion and Analysis Of Financial Condition and Results of Operations ...